Cargando…
Multiple Sclerosis Management During the COVID-19 Pandemic
PURPOSE OF REVIEW: COVID-19 has posed a continuously evolving challenge for providers caring for patients with multiple sclerosis (MS). While guidelines from national and international organizations came quickly, these have required constant reassessment and modification as the pandemic has progress...
Autores principales: | Hollen, Chris, Bernard, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185132/ https://www.ncbi.nlm.nih.gov/pubmed/35687314 http://dx.doi.org/10.1007/s11910-022-01211-9 |
Ejemplares similares
-
Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020) -
Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016) -
Axonal Damage in Pediatric Multiple Sclerosis
por: Kuntz, Nancy L.
Publicado: (2015) -
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices
por: Chou, I-Jun, et al.
Publicado: (2016) -
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)